Meng, Y., Wei, W., Li, Q., Yang, F., Wan, T., Li, J. (2026). Neoadjuvant disitamab vedotin plus carboplatin in HER2-expressing advanced ovarian cancer: A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5556